产品
编 号:F040463
分子式:C81H156N10O13S
分子量:1510.23
产品类型
结构图
CAS No: 112208-00-1
联系客服
产品详情
生物活性:
Pam3CSK4 is a toll-like receptor 1/2 (TLR1/2) agonist with an EC50 of 0.47 ng/mL for human TLR1/2.
体内研究:
Pam3CSK4 (5 mg/kg; i.p.; once a day for 9 days) alters brain, spleen and liver weights in neonatal mice.Animal Model:Time-mated pregnant C57BL/6 wild-type mice; B6.129-Tlr2tm1Kir/J (TLR2 -deficient) mice
Dosage:5 mg/kg
Administration:Intraperitoneally (i.p.); once a day for 9 days
Result:After repeated administration from postnatal day (PND3) to PND11, brain weight was decreased compared with endotoxin-free saline-treated animals at PND12. Decreased volume of cerebral gray matter, white matter in the forebrain and cerebellar molecular layer that was accompanied by an increase in spleen and liver weight at PND12.
体外研究:
Pam3CSK4 is a TLR1/2 heterodimer recognises triacylated lipopeptides.Pam3CSK4 (1 μg/mL) enhances the antibacterial functions of granulocyte macrophage-colony stimulating factor (GM-CSF) induced neutrophils to Methicillin-resistant Staphylococcus aureus.